This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More
by Zacks Equity Research
Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.
LLYPositive Net Change AMGNPositive Net Change GILDPositive Net Change EXELPositive Net Change
biotechs medical
Medical Device Stocks' Earnings on Feb 1: RVTY, CAH & More
by Debanjana Dey
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
BDXPositive Net Change CNMDPositive Net Change CAHPositive Net Change SRDXNegative Net Change RVTYPositive Net Change
earnings medical medical-devices
Insurance Stocks' Q4 Earnings Due on Jan 31: AFL, MET & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
MTGPositive Net Change METPositive Net Change AFLPositive Net Change AXSPositive Net Change SIGIPositive Net Change
earnings insurance
Medical Products Q4 Earnings Due on Jan 31: BSX, TMO & ALGN
by Urmimala Biswas
Medical Products companies' fourth-quarter results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO and ALGN fare this time.
BSXPositive Net Change ALGNPositive Net Change TMOPositive Net Change
earnings medical
Drug, Biotech Stocks' Q4 Earnings Due on Jan 31: NVO, NVS & GSK
by Ahan Chakraborty
Let's look at three biotech/drug companies, NVO, NVS and GSK, slated to release quarterly results on Jan 31.
GSKPositive Net Change NVSPositive Net Change JNJPositive Net Change NVOPositive Net Change
biotechnology biotechs medical pharmaceuticals
Medical Product Stocks' Q4 Earnings Due on Jan 30: SYK & More
by Indrajit Bandyopadhyay
Fourth-quarter results of Medical Product companies are likely to reflect a year-over-year improvement in revenues. Let's see how SYK, COR and ARAY fare this time around.
ARAYPositive Net Change SYKPositive Net Change CORPositive Net Change
medical medical-devices
3 Asset Management Stocks Set to Pull Off Earnings Beat in Q4
by Swayta Shah
Driven by solid market performance and moderate improvement in the operating backdrop, asset managers - SEI Investments (SEIC), T. Rowe Price (TROW) and Principal Financial (PFG) - are set to surpass estimates in Q4.
BLKPositive Net Change TROWPositive Net Change PFGPositive Net Change SEICPositive Net Change
earnings finance
Airline Stocks' Q4 Earnings Roster for Jan 25: AAL, ALK, LUV
by Zacks Equity Research
Investors interested in the Airline industry can watch out for fourth-quarter 2023 earnings reports of AAL, ALK and LUV, which are slated to release on Jan 25.
LUVPositive Net Change AALPositive Net Change ALKPositive Net Change
earnings transportation
Biotech/Drug Stocks Q3 Earnings Due Nov 7: GILD, PRGO, VTRS & More
by Zacks Equity Research
Let us take a look at what's in store for biotech/drug stocks GILD, PRGO, VTRS, SAGE and IOVA, which are scheduled to report on Nov 7.
BMYPositive Net Change GILDPositive Net Change PRGONegative Net Change SAGENegative Net Change IOVANegative Net Change VTRSPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
Energy Stocks' Q3 Earnings Roster for Nov 7: CIVI, DVN, WTI
by Nilanjan Banerjee
Favorable commodity prices likely to have aided the upstream business. Let's see how Civitas Resources (CIVI), Devon Energy (DVN) and W&T Offshore (WTI) are placed ahead of Q3 earnings.
DVNPositive Net Change WTIPositive Net Change CIVIPositive Net Change
oil-energy
Service Stocks' Nov 2 Earnings Roster: BR, APTV & PLTR
by Zacks Equity Research
Investors interested in the Business Services sector can watch out for earnings reports of BR, APTV and PLTR, to be released on Nov 2.
BRPositive Net Change APTVPositive Net Change PLTRNegative Net Change
business-services earnings
Medical Product Stocks' Q3 Earnings Due on Nov 1: SYK & More
by Indrajit Bandyopadhyay
Third-quarter results of Medical Product companies are likely to reflect a year-over-year decline. Let's see how SYK, COR, BAX, FMS and XRAY fare this time around.
BAXPositive Net Change SYKPositive Net Change XRAYPositive Net Change FMSPositive Net Change CORPositive Net Change
medical medical-devices
Utility Stocks Reporting Q3 Earnings on Nov 2: ED, DUK & More
by Tanvi Sarawagi
Let's focus on utilities like ED, DUK, EXC, PNW, LNT and NRG, which are scheduled to release third-quarter 2023 earnings on Nov 2.
EXCPositive Net Change NRGNegative Net Change DUKPositive Net Change EDPositive Net Change PNWPositive Net Change LNTPositive Net Change
utilities
MedTech Stocks' Q3 Earnings Due on Nov 1: IDXX, EXAS & More
by Urmimala Biswas
MedTech companies' third-quarter results are likely to reflect a year-over-year decline. Let's see how IDXX, EXAS, TNDM and NVST fare this time.
IDXXNegative Net Change EXASPositive Net Change TNDMNegative Net Change NVSTPositive Net Change
earnings medical
Insurance Stocks' Q3 Earnings Due on Nov 1: AFL, MET & More
by Zacks Equity Research
High interest rates and renewals favor insurers in Q3 but are partly offset by costs and CAT losses. AFL, MET, AIG, ALL & PRU will release earnings on Nov 1.
AIGPositive Net Change METPositive Net Change PRUPositive Net Change AFLPositive Net Change ALLPositive Net Change
earnings finance insurance
Utilities Due to Report Q3 Earnings on Nov 1: NI, ETR & More
by Jewel Saha
Let's focus on utilities like NI, ETR, AWK, DTE and EIX, scheduled to release their third-quarter earnings on Nov 1.
NIPositive Net Change ETRPositive Net Change EIXPositive Net Change DTEPositive Net Change AWKPositive Net Change
utilities
P&C Insurers to Post Q3 Earnings on Nov 1: SIGI, AXS & More
by Sushmita Sarker
Solid retention rates, continued rate increases and accelerated digitalization, partly offset by significant catastrophe losses, are likely to have influenced the third-quarter performances of SIGI, AXS, NMIH and AFG.
AXSPositive Net Change AFGPositive Net Change SIGIPositive Net Change NMIHPositive Net Change
insurance
Solar Stocks to Watch for Earnings on Nov 1: RUN, SEDG & SPWR
by Aparajita Dutta
Earnings from the Oil-Energy sector, which houses all solar stocks, are expected to have declined 35.5% from the prior-year quarter's reported figure. Let's see how RUN, SEDG and SPWR report.
SPWRNegative Net Change ENPHNegative Net Change SEDGNegative Net Change RUNNegative Net Change
earnings oil-energy
Medical Device Stocks to Watch for Earnings on Nov 1: MCK & More
by Indrajit Bandyopadhyay
Medical Device companies' Q3 results are likely to reflect strength in customer demand. Let's see how MCK, QDEL, GKOS and NARI are placed ahead of their earnings release.
MCKPositive Net Change QDELNegative Net Change GKOSPositive Net Change NARINegative Net Change
medical medical-devices
Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY
by Zacks Equity Research
Let's take a look at three biotech/drug companies, AMGN, PFE and INCY, slated to release quarterly results on Oct 31.
NVSPositive Net Change PFEPositive Net Change AMGNPositive Net Change INCYPositive Net Change
biotechs pharmaceuticals
Utilities Due to Report Q3 Earnings on Oct 26: FE, PCG & More
by Jewel Saha
Let's focus on utilities like FE, PCG, CMS, XEL and CNP, which are scheduled to release third-quarter earnings on Oct 26.
XELPositive Net Change FEPositive Net Change PCGPositive Net Change CMSPositive Net Change CNPPositive Net Change
utilities
MedTech Stocks to Watch for Earnings on Oct 26: WST, DXCM & More
by Debanjana Dey
MedTech companies' Q3 results are likely to reflect strength in customer demand. Let's see how WST, DXCM, MMSI and ITGR are placed ahead of their earnings releases.
DXCMPositive Net Change MMSIPositive Net Change WSTPositive Net Change ITGRNegative Net Change
earnings medical medical-devices
Drug, Biotech Stocks' Q3 Earnings Due on Oct 26: BMY, MRK, BPMC
by Ahan Chakraborty
Let's look at three biotech/drug companies, BMY, MRK and BPMC, slated to release quarterly results on Oct 26.
BMYPositive Net Change JNJPositive Net Change MRKPositive Net Change BPMCNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Medical Device Stocks' Q3 Earnings Due on Oct 26: BSX, BIO & More
by Urmimala Biswas
Medical Device companies' third-quarter results are likely to reflect a year-over-year decline. Let's see how BSX, BIO, EW and LH fare this time.
BSXPositive Net Change LHPositive Net Change EWNegative Net Change BIOPositive Net Change
earnings medical
Auto Stocks' Q3 Earnings Lineup for Oct 26: F, HOG & More
by Rimmi Singhi
F, HOG, LKQ, OSK, and LEA are slated to release their Q3 results tomorrow. Our model anticipates an earnings beat for all companies except LKQ.
FPositive Net Change HOGPositive Net Change LEAPositive Net Change OSKPositive Net Change LKQPositive Net Change
auto-tires-trucks earnings